" rel="stylesheet">
Skip Main Navigation
Page Content
This event has ended

SBIR Program Update with Patricia Weber, National Cancer Institute


Friday, October 19, 2012 from 11:30 AM to 1:30 PM

SBIR Program Update with Patricia Weber, National...

Ticket Information

Ticket Type Sales End Price Fee Quantity
OCTANe Members & General Admission Ended Free $0.00
OCTANe Membership and Free Admission Ended $300.00 $0.00

Share SBIR Program Update with Patricia Weber, National Cancer Institute

Event Details

Dr Weber will present an overview of the SBIR/STTR program at the NIH and will discuss recent rule changes and new requirements, in addition to providing advice on how to apply for these competitive programs. She will discuss new non-dilutive funding opportunities available through the NCI for early-stage companies to develop the next generation of cancer technologies and therapeutics. Dr Weber will be available for one-on-one meetings with attendees. If interested, please send a one page company description to luis.vasquez@octaneoc.org.

Patricia A Weber, DrPH - Program Director, National Cancer Institute SBIR Development Center
Dr. Weber completed her Masters and Doctorate in Public Health with an emphasis in Biomedical Sciences at the School of Public Health, University of California at Berkeley. She was Director of Microbiology and Immunology at a San Diego-based biotech company that focused on the discovery and development of peptide therapeutics. She then moved to western Montana where she was the Team Leader of Cardiovascular Pharmacology at Ribi ImmunoChem Research (currently GSK) in Hamilton, MT. In addition to managing the preclinical development efforts of an intravenous biological product for the prevention of ischemia/reperfusion injury associated with cardiopulmonary bypass procedures, she also worked on licensing the therapeutic to potential pharmaceutical partners. She joined the International Heart Institute of Montana in 2000 where she managed the Tissue Engineering and Surgical Research Laboratories. Her work involved the preclinical development of cardiovascular devices including heart valves, bioengineered blood vessels and novel, stent-based devices. She implemented Good Laboratory Practices (GLP), thus allowing the Institute to perform studies to be included in submissions to the FDA for approval of new medical devices. Dr Weber began work at the National Institute of Health in the National Cancer Institute’s Small Business Innovation Research (SBIR) Development Center in Oct of 2008. The SBIR Development Center is a division at the NCI that manages more than $117 million in technology projects within the small business community to accelerate the progress of cancer research. Her area of emphasis is in cancer prevention, digital health, therapeutics, and biologics.

More information:
Thirteen new contract topics available with an application deadline of Nov 13:
A new program announcement in the digital health space:
Have questions about SBIR Program Update with Patricia Weber, National Cancer Institute ? Contact OCTANe

When & Where

65 Enterprise
Aliso Viejo, CA 92656

Friday, October 19, 2012 from 11:30 AM to 1:30 PM

  Add to my calendar
SBIR Program Update with Patricia Weber, National Cancer Institute
Aliso Viejo, CA Events Class

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.